Publikationer pr. år
Publikationer pr. år
Personlig profil
Expertise
Anders H. Kverneland is a medical doctor by training and a dedicated cancer immune therapy researcher. He is experienced in running clinical trials with experimental immune therapy and has made his PhD within adoptive cell therapy. He is deeply involved in translation research where he is analyzing sample material collected during clincial trials to gain insights that can design future therapies.
Primære forskningsområder
Immunology; Cancer immunology;
Aktuel forskning
Anders H. Kverneland has since 2021 been employed as a postdoctural research fellow on the KU BRIDGE programme. He is working on bringing novel methodologies within mass spectometric protein analyses (proteomics) into patient samples collected at CCIT-DK. The current aim is to improve management of immune-related toxicities by providing biomarkers that can guide clinical decisions.
Mulige interessekonflikter
None
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Anders Kverneland er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
- 1 Lignende profiler
Netværk
Seneste eksterne samarbejde på lande-/områdeniveau. Dyk ned i detaljerne ved at klikke på prikkerne eller
-
Proteomics to study cancer immunity and improve treatment
Franciosa, G., Kverneland, A. H., Jensen, A. W. P., Donia, M. & Olsen, J. V., 4 jan. 2023, (E-pub ahead of print) I: Seminars in Immunopathology.Publikation: Bidrag til tidsskrift › Review › peer review
-
Differential ultracentrifugation enables deep plasma proteomics through enrichment of extracellular vesicles
Kverneland, A. H., Østergaard, O., Emdal, K. B., Svane, I. M. & Olsen, J. V., 18 nov. 2022, (E-pub ahead of print) I: Proteomics. s. e2200039Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy
Chamberlain, C. A., Bennett, E. P., Kverneland, A. H., Svane, I. M., Donia, M. & Met, Ö., 17 mar. 2022, I: Molecular therapy oncolytics. 24, s. 417-428 12 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Adoptive cell therapy across cancer diagnoses
Kverneland, A., 11 jun. 2021, University of Copenhagen.Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling
-
Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types
Kverneland, A. H., Chamberlain, C. A., Borch, T. H., Nielsen, M., Mørk, S. K., Kjeldsen, J. W., Lorentzen, C. L., Jørgensen, L. P., Riis, L. B., Yde, C. W., Met, Ö., Donia, M. & Marie Svane, I., 4 okt. 2021, I: Journal for ImmunoTherapy of Cancer. 9, 10, e003499.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
13 Citationer (Scopus)